You are here

  • Home
  • Archive
  • Volume 28, Issue Suppl 1
  • 4CPS-301 Association of antibiotics and proton pump inhibitors on clinical activity of firstline pembrolizumab for non-small cell lung cancer: 2 years of real world data

Article info

Article menu

Download PDFPDF

Section 4: Clinical pharmacy services
4CPS-301 Association of antibiotics and proton pump inhibitors on clinical activity of firstline pembrolizumab for non-small cell lung cancer: 2 years of real world data
Free

Authors

Citation

Castro Balado A, Tourís Lores M, Álvarez Sánchez R, et al
4CPS-301 Association of antibiotics and proton pump inhibitors on clinical activity of firstline pembrolizumab for non-small cell lung cancer: 2 years of real world data
European Journal of Hospital Pharmacy 2021;28:A65.

Publication history

  • First published March 14, 2021.
Online issue publication 
March 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.